Today, looking through PubMed Health, a medical literature database curated by the United States National Library of Medicine and The National Institutes of Health, I found another article linking poor neonatal outcomes and to birth defects prenatal exposure to maternal selective serotonin reuptake inhibitor drugs (SSRIs). This article, titled “Developmental effects of SSRIs: lessons learned from animal studies.” was by X. Borue et al. and appeared in the October, 2007 edition of International Journal of Developmental Neuroscience.
Noting that “SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri- and postnatal development”, this team aimed to “assess the current research done in animals that sheds light on the role of serotonin during development and the possible effects of SSRIs.”
Results of their analysis illustrated that “Experimental studies in rodents show that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behaviors that persist into adulthood.” (emphasis added)
Because the manufacturer of many SSRI drugs like Prozac, Paxil, and Zoloft have failed time and again to adequately inform women of these and other serious risks, SSRI birth defect lawsuits have been filed around the world in great number.
If you or a loved one used SSRIs and gave birth to a child with a congenital malformation or who had perinatal complications, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529